What is more dangerous – the disease, the vaccine or the government? Using governmentality theory to understand vaccine hesitancy among Israeli citizens in times of corona

References

• Aran, D. (2021). Estimating real-world COVID-19 vaccine effectiveness in Israel using aggregated counts. medRxiv BMJ, Yale. Accessed 21 Jul 2022. https://www.medrxiv.org/content/10.1101/2021.02.05.21251139v2
   Google Scholar
• Aven, T., & Bouder, F. (2020). The COVID-19 pandemic: How can risk science help? Journal of Risk Research, 23(7–8), 849–854. https://doi.org/10.1080/13669877.2020.1756383
   Web of Science ®Google Scholar
• Birner, R. (2018). Bioeconomy concepts. In I. Lewandowski (Ed.), Bioeconomy (pp. 17–38). Springer.
   Google Scholar
• Bloom, B. R., Nowak, G. J., & Orenstein, W. (2020). ‘When will we have a vaccine?’—Understanding questions and answers about Covid-19 vaccination. New England Journal of Medicine, 383(23), 2202–2204. https://doi.org/10.1056/NEJMp2025331
   PubMed Web of Science ®Google Scholar
• Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa
   Google Scholar
• Brown, P., & Calnan, M. (2010). Braving a faceless new world? Conceptualizing trust in the pharmaceutical industry and its products. Health, 16(1), 57–75. https://doi.org/10.1177/1363459309360783
   PubMed Web of Science ®Google Scholar
• Brown, P. (2020). Studying COVID-19 in light of critical approaches to risk and uncertainty: Research pathways, conceptual tools, and some magic from Mary Douglas. Health, Risk & Society, 22(1), 1–14. https://doi.org/10.1080/13698575.2020.1745508
   Web of Science ®Google Scholar
• Brown, P., & Galantino, M. G. (2020). Theorising–problematising categories: Understanding the Covid-19 pandemic through the sociology of risk and uncertainty. The European Sociologist, 45(1). https://iris.uniroma1.it/bitstream/11573/1416084/2/Brown%20and%20Galantino%20-%20Problematising%20categories.docx.pdf
   Google Scholar
• Chevallier, C., Hacquin, A. S., & Mercier, H. (2021). COVID-19 vaccine hesitancy: Shortening the last mile. Trends in Cognitive Sciences, 25(5), 331–333. https://doi.org/10.1016/j.tics.2021.02.002
   PubMed Web of Science ®Google Scholar
• Dew, K., & Donovan, S. (2020). Vaccines, polarising divides and the role of public health. Critical Public Health, 30(1), 1–3. https://doi.org/10.1080/09581596.2020.1702286
   Web of Science ®Google Scholar
• Dubé, E., Laberge, C., Guay, M., Bramadat, P., Roy, R., & Bettinger, J. A. (2013). Vaccine hesitancy: An overview. Human Vaccines & Immunotherapeutics, 9(8), 1763–1773. https://doi.org/10.4161/hv.24657
   PubMed Web of Science ®Google Scholar
• Dubé, E., & MacDonald, N. E. (2020). How can a global pandemic affect vaccine hesitancy? Expert Review of Vaccines, 19(10), 899–901. https://doi.org/10.1080/14760584.2020.1825944
   PubMed Web of Science ®Google Scholar
• Eyal, G. (2019). The crisis of expertise. John Wiley & Sons.
   Google Scholar
• Eyal, G. (2022). Response to Riccardo Emilio Chesta’s ‘what is critical about the crisis of expertise? A review of Gil Eyal’s the crisis of expertise (2019, Cambridge: Polity Press)’. International Journal of Politics, Culture, and Society 35, 119–127. https://doi.org/10.1007/s10767-021-09403-w
   PubMed Web of Science ®Google Scholar
• Foucault, M. (1978). The history of sexuality: An introduction. ( R. Hurley, Trans. Vol. 1). Random House.
   Google Scholar
• Foucault, M. (1991). Governmentality. In C. Gordon & P. Miller (Eds.), The Foucault effect: Studies in governmentality (pp. 87–104). University of Chicago.
   Google Scholar
• Foucault, M. (1998). The will to knowledge: The history of sexuality 1. Penguin Books.
   Google Scholar
• Foucault, M. (2003). ‘Society must be defended,’ lectures at the college de France, 1975–76. David Macey.
   Google Scholar
• Gordon, C. (1991). Governmental rationality: An introduction. In G. Burchell, C. Gordon, & P. Miller (Eds.), Studies in governmentality (pp. 1–52). Chicago University Press.
   Google Scholar
• Green, M. S., Abdullah, R., Vered, S., & Nitzan, D. (2021). A study of ethnic, gender and educational differences in attitudes toward COVID-19 vaccines in Israel–implications for vaccination implementation policies. Israel Journal of Health Policy Research, 10(1), 1–12. https://doi.org/10.1186/s13584-021-00458-w
   PubMed Web of Science ®Google Scholar
• Gurwitz, D. (2021). COVID-19 vaccine hesitancy: Lessons from Israel. Vaccine, 39(29), 3785–3786. https://doi.org/10.1016/j.vaccine.2021.05.085
   PubMed Web of Science ®Google Scholar
• Höcker, A. (2020). ‘Everybody makes it until they don’t’: Survival as metaphor. The Germanic Review: Literature, Culture, Theory, 95(2), 114–127. https://doi.org/10.1080/00168890.2020.1751042
   Web of Science ®Google Scholar
• Israel Ministry of Health. (2020). Real-world eipdemiological evidence: Collaboration agreement. https://govextra.gov.il/media/30806/11221-moh-pfizer-collaboration-agreement-redacted.pdf
   Google Scholar
• Israel Ministry of Health. (2021). Corona virus in Israel - general situation. Retrieved November 12, 2021 https://datadashboard.health.gov.il/COVID-19/general
   Google Scholar
• Keshet, Y. (2020). Fear of panoptic surveillance: Using digital technology to control the COVID-19 epidemic. Israel Journal of Health Policy Research, 9(1), 1–8. https://doi.org/10.1186/s13584-020-00429-7
   Web of Science ®Google Scholar
• Larson, H. J., Jarrett, C., Schulz, W. S., Chaudhuri, M., Zhou, Y., Dube, E., Schuster, M., MacDonald, N. E., & Wilson, R. (2015). Measuring vaccine hesitancy: The development of a survey tool. Vaccine, 33(34), 4165–4175. https://doi.org/10.1016/j.vaccine.2015.04.037
   PubMed Web of Science ®Google Scholar
• Lee, J. K. (2021). Can we reach a 70% level of herd immunity to return to normality? Osong Public Health and Research Perspectives, 12(2), 51. https://doi.org/10.24171/j.phrp.2021.12.2.01
   PubMedGoogle Scholar
• Marien, S., & Werner, H. (2019). Fair treatment, fair play? The relationship between fair treatment perceptions, political trust and compliant and cooperative attitudes cross-nationally. European Journal of Political Research, 58(1), 72–95. https://doi.org/10.1111/1475-6765.12271
   Web of Science ®Google Scholar
• McCormick, K., & Kautto, N. (2013). The bioeconomy in Europe: An overview. Sustainability, 5(6), 2589–2608. https://doi.org/10.3390/su5062589
   Web of Science ®Google Scholar
• Muhsen, H., Gerber, Y., & Gecel, A. (2021). Vaccines to combat the new CoV-SARS2 virus: From clinical trials to use in the population. The Sackler Faculty of Medicine, Tel Aviv University (Hebrew). Retrieved April 10, 2021. http://www.israelhpr.org.il/wp-content/uploads/2021/04/SARS-Cov-2-vaccines_Apr17-2021_School-of-Public-Health-.pdf
   Google Scholar
• Ojakangas, M. (2005). Impossible dialogue on bio-power: Agamben and Foucault. Foucault Studies, 2, 5–28. https://doi.org/10.22439/fs.v0i2.856
   Google Scholar
• Oksanen, A., Kaakinen, M., Latikka, R., Savolainen, I., Savela, N., & Koivula, A. (2020). Regulation and trust: 3-month follow-up study on COVID-19 mortality in 25 European countries. JMIR Public Health and Surveillance, 6(2), e19218. https://doi.org/10.2196/19218
   PubMedGoogle Scholar
• Petersen, A., & Krisjansen, I. (2015). Assembling ‘the bioeconomy’: Exploiting the power of the promissory life sciences. Journal of Sociology, 51(1), 28–46. https://doi.org/10.1177/1440783314562314
   Web of Science ®Google Scholar
• Robinson, O. C. (2022). Conducting thematic analysis on brief texts: The structured tabular approach. Qualitative Psychology, 9(2), 194–208. Advance online publication. https://doi.org/10.1037/qup0000189
   Google Scholar
• Rose, N. (2007). The politics of life itself: Biomedicine, power and subjectivity in the twenty first century. Princeton University Press.
   Google Scholar
• Rosen, B., Waitzberg, R., & Israeli, A. (2021a). Israel’s rapid rollout of vaccinations for COVID-19. Israel Journal of Health Policy Research, 10(1), 1–14. https://doi.org/10.1186/s13584-021-00440-6
   PubMedGoogle Scholar
• Rosen, B., Waitzberg, R., Israeli, A., Hartal, M., & Davidovitch, N. (2021b). Addressing vaccine hesitancy and access barriers to achieve persistent progress in Israel’s COVID-19 vaccination program. Israel Journal of Health Policy Research, 10(1), 1–20. https://doi.org/10.1186/s13584-021-00481-x
   PubMedGoogle Scholar
• Sfetcu, N. 2020. Biopolitica în pandemia COVID-19. SetThings, Retrieved october 8, 2020. https://doi.org/10.13140/RG.2.2.13265.56161
   Google Scholar
• Soares, P., Rocha, J. V., Moniz, M., Gama, A., Laires, P. A., Pedro, A. R., Dias, S., Leite, A., & Nunes, C. (2021). Factors associated with COVID-19 vaccine hesitancy. Vaccines, 9(3), 300. https://doi.org/10.3390/vaccines9030300
   Web of Science ®Google Scholar
• Troiano, G., & Nardi, A. (2021). Vaccine hesitancy in the era of COVID-19. Public Health, 194, 225–245. https://doi.org/10.1016/j.puhe.2021.02.025
   Web of Science ®Google Scholar
• Wise, J. (2021). Covid-19: Pfizer BioNTech vaccine reduced cases by 94% in Israel, shows peer reviewed study. BMJ, 372(n567). https://doi.org/10.1136/bmj.n567. pmid: 33632676.
   PubMedGoogle Scholar
• World Health Organization. (2014). Report of the Sage working group on vaccine hesitancy. https://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf
   Google Scholar